Company news
SKRR Exploration, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
SKRR Increases Olson Gold Project Land Package in Northern Saskatchewan
June 23, 2020
SKRR Announces Work Program for Leland Gold Project, Saskatchewan
June 8, 2020
SKRR Exploration Inc. Announces Private Placement
June 2, 2020
SKRR Commences Exploration on Olson Gold Project, Northern Saskatchewan
June 2, 2020
SKRR Exploration Inc. and Taiga Gold Execute Option Agreement for Leland Gold Project, Saskatchewan
May 21, 2020
SKRR Amends Option Agreement to Acquire the Irving Lake Property in Saskatchewan, Canada
May 14, 2020
SKRR Signs Option Agreement to Acquire the Irving Lake Property in Saskatchewan, Canada
April 27, 2020
SKRR Exploration Inc. Reports 2020 AGM Results
March 23, 2020
SKRR Exploration Inc. Announces Change of Venue for Annual General and Special Meeting to Be Held on March 23, 2020
March 17, 2020
SKRR Closes Ithingo Lake Property Option Agreement
March 13, 2020
SKRR Exploration Inc. - Early Warning Report Filed Pursuant to National Instrument 62-103
March 12, 2020
SKRR Signs Option Agreement to Acquire the Ithingo Lake Gold Project in Saskatchewan, Canada
March 4, 2020
SKRR Exploration Inc. Signs Definitive Agreement to Acquire the Cathro Gold Project, Saskatchewan
February 12, 2020
Canex Drill Update and TSX Approval on Property Extension
November 5, 2015
Canex and Fission 3.0 Extend Clearwater West Property Option Agreement
October 21, 2015
Canex Encounters 2,333 cps Anomalous Radioactivity by Down-hole Gamma Probe in 3rd Drill Hole at Clearwater West
August 4, 2015
Canex Collars First Hole and Begins Drilling with JV Partner at Clearwater West
July 27, 2015
Canex and Fission 3.0 Mobilize Drill Rig for Seven Hole Drill Program at Clearwater West
July 20, 2015
Canex Appoints New CFO
July 14, 2015
Canex Announces Closing Of Oversubscribed Second Tranche In Non-Brokered Private Placement
June 30, 2015
Canex appoints Ross McElroy as Technical Advisor and announces non-brokered private placement
May 14, 2015
Mick Shmazian Joins Brades Resource as Advisor, Sets Options
March 6, 2015
Brades Resource Corp And Fission 3.0 Target Large Anomaly Cluster On The Clearwater West Property
October 15, 2014
Ryan Kalt Announces Acquisition of Common Shares of Brades Resource Corp. - ("BRA")
August 15, 2013
Oncothyreon to begin trading today on NASDAQ and TSX
December 11, 2007
Court issues final order approving Biomira's move to U.S. and name change to Oncothyreon
December 5, 2007
Biomira Shareholders Approve Move to U.S.
December 4, 2007
Biomira Inc. receives Nasdaq delisting notification
November 5, 2007
Biomira Inc. announces date for special meeting of shareholders; Oncothyreon Inc. registration statement declared effective
November 1, 2007
Biomira announces third quarter 2007 financial results
November 1, 2007
Biomira to present at the Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
October 30, 2007
New data may help guide the clinical development of Biomira's PX-478 and PX-866
October 24, 2007
Biomira to present at the BIO InvestorForum 2007
October 3, 2007
Biomira announces plan to change name to Oncothyreon
September 27, 2007
Biomira Announces Plan to Reincorporate in the United States
September 12, 2007
Stimuvax(R) Phase II data highlight three-year survival results for patients with non-small cell lung cancer
September 5, 2007
Biomira initiates Phase 1 trial of PX-478 in patients with advanced metastatic cancers
August 28, 2007
Biomira and Merck KGaA sign amended and restated collaboration and supply agreements related to Stimuvax(R)
August 8, 2007
Biomira announces second quarter 2007 financial results
August 2, 2007
Biomira appoints industry veteran as Chief Operating Officer
July 17, 2007
Biomira files investigational new drug application for PX-478, a novel inhibitor of hypoxia-inducible factor-1 alpha
July 3, 2007
Biomira to Present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
May 8, 2007
Biomira Inc. announces first quarter 2007 results
April 26, 2007
Biomira selects PX-866 as clinical development candidate and presents promising preclinical data at AACR
April 16, 2007
Biomira reports Full year and Fourth Quarter 2006 Financial Results
March 8, 2007
Biomira to present at two upcoming investor conferences
March 7, 2007
Biomira restates U.S. GAAP note disclosure for non-cash charges
March 2, 2007
Biomira announces March 8th webcast of its fourth quarter and full year 2006 financial results conference call
March 2, 2007
First patient enrolled in Stimuvax(R) Phase III clinical trial in patients with non-small cell lung cancer
February 26, 2007
Biomira to present at the BIO CEO & Investor Conference 2007
February 8, 2007
Decks
- Investor Presentation (April 2023)
Investor deck · 28 slides · April 2023
- Investor Presentation (February 2023)
Investor deck · 28 slides · February 2023
- Investor Presentation (March 2022)
Investor deck · 25 slides · March 2022